Aquestive Therapeutics, Inc. (AQST) Stock Analysis

Free AI-powered analysis and research for Aquestive Therapeutics, Inc. stock

Sector: Healthcare

Analyze Aquestive Therapeutics, Inc. (AQST) Stock

Aquestive Therapeutics, Inc. (AQST) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into AQST stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Aquestive Therapeutics, Inc. stock.

Analyze AQST Now →

📰 Latest Update

Aquestive Therapeutics Targets Q3 Anaphylm Resubmission After FDA CRL Flags Human Factors, PK Data

Wed, March 11, 2026 at 6:04 AM UTC 4 min read

Aquestive Therapeutics announced plans to resubmit its Anaphylm application in Q3 after receiving a Complete Response Letter (CRL) from the FDA, which cited concerns regarding human factors and pharmacokinetic (PK) data. This resubmission is crucial for investors as it could potentially lead to the approval of Anaphylm, a treatment for severe allergic reactions, and impact the company's future revenue and market position. Investors will be closely monitoring the progress and outcomes of this resubmission.

Read full article →